IMNN-001 Demonstrates Clinical Promise in Advanced Ovarian Cancer
LAWRENCEVILLE, N.J., July 21, 2026 IMUNON, Inc. has announced positive preliminary Phase 2 minimal residual disease (MRD) clinical data...
genetic testing
Advertisement
Myriad Launches FirstGene for Earlier Prenatal Genetic Screening
SALT LAKE CITY, Utah, July 21, 2026 Myriad Genetics has officially launched the FirstGene® Multiple Prenatal Screen, introducing what...
Endeavor Health Unveils Advanced Genetic Test for Heart Disease
EVANSTON, Ill., June 2, 2026 Researchers at Endeavor Health have developed a groundbreaking genetic screening tool designed to provide...
Myriad Genetics Advances Precision Medicine at Q4 2025 Forums
Dateline — SALT LAKE CITY, November 11, 2025:Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostic testing...
Advertisement
